John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$172M |
| 2 |
Johnson & Johnson
JNJ
|
+$161M |
| 3 |
American Express
AXP
|
+$161M |
| 4 |
Apple
AAPL
|
+$156M |
| 5 |
Emerson Electric
EMR
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$172M |
| 2 |
AGN
Allergan Inc
AGN
|
+$139M |
| 3 |
Wynn Resorts
WYNN
|
+$111M |
| 4 |
AbbVie
ABBV
|
+$94.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$94.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.92% |
| 2 | Technology | 11.5% |
| 3 | Industrials | 10.9% |
| 4 | Healthcare | 10.87% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWC
1
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $163M | 0.76% |
1,088,280
-1,423
| -0.1% | -$212K |
|
|
2
Emerson Electric
EMR
$87.7B
| $161M | 0.75% |
2,851,517
+2,581,023
| +954% | +$150M |
|
|
BHI
3
DELISTED
Baker Hughes
BHI
| $161M | 0.75% |
2,532,346
+194,621
| +8% | +$11.7M |
|
|
4
Apple
AAPL
$4.51T
| $161M | 0.75% |
+5,175,016
| New | +$156M |
|
|
5
Johnson & Johnson
JNJ
$651B
| $160M | 0.75% |
1,592,787
+1,586,463
| +25,086% | +$161M |
|
|
6
Intel
INTC
$476B
| $159M | 0.74% |
+5,084,443
| New | +$172M |
|
|
7
American Express
AXP
$227B
| $158M | 0.73% |
2,018,573
+1,938,664
| +2,426% | +$161M |
|
8
Philip Morris
PM
$293B
| $158M | 0.73% |
2,091,174
+208,324
| +11% | +$16.9M |
|
|
DTV
9
DELISTED
DIRECTV COM STK (DE)
DTV
| $149M | 0.69% |
1,752,056
+62,455
| +4% | +$5.4M |
|
10
Dollar General
DG
$27.2B
| $139M | 0.65% |
1,838,462
+705,461
| +62% | +$49.9M |
|
11
Microsoft
MSFT
$3.59T
| $136M | 0.63% |
3,339,319
+350,779
| +12% | +$15.3M |
|
12
Comcast
CMCSA
$95.3B
| $133M | 0.62% |
4,723,838
+3,633,642
| +333% | +$104M |
|
13
Invesco QQQ Trust
QQQ
$486B
| $131M | 0.61% |
1,244,368
+1,143,768
| +1,137% | +$120M |
|
14
Merck
MRK
$376B
| $131M | 0.61% |
2,380,490
+1,021,628
| +75% | +$57.8M |
|
15
PepsiCo
PEP
$196B
| $128M | 0.6% |
1,339,531
+1,138,374
| +566% | +$110M |
|
|
FDO
16
DELISTED
FAMILY DOLLAR STORES
FDO
| $122M | 0.57% |
1,539,399
+793,498
| +106% | +$61.9M |
|
17
General Dynamics
GD
$104B
| $122M | 0.57% |
898,027
-215,253
| -19% | -$29.5M |
|
18
Crown Castle
CCI
$32.1B
| $122M | 0.57% |
1,476,053
+550,567
| +59% | +$46.9M |
|
19
Marathon Petroleum
MPC
$101B
| $121M | 0.56% |
2,354,578
-816,884
| -26% | -$39.2M |
|
|
LO
20
DELISTED
LORILLARD INC COM STK
LO
| $119M | 0.56% |
1,827,303
+503,100
| +38% | +$33.5M |
|
21
Bath & Body Works
BBWI
$3.92B
| $118M | 0.55% |
1,547,174
+730,523
| +89% | +$52.8M |
|
22
Mondelez International
MDLZ
$82.3B
| $118M | 0.55% |
3,257,705
+1,092,179
| +50% | +$39.5M |
|
23
Teva Pharmaceuticals
TEVA
$43.5B
| $115M | 0.53% |
1,840,825
+31,800
| +2% | +$1.85M |
|
24
Chipotle Mexican Grill
CMG
$46.7B
| $114M | 0.53% |
8,762,250
+6,033,550
| +221% | +$82.4M |
|
25
Zoetis
ZTS
$32.1B
| $107M | 0.5% |
2,313,207
-219,537
| -9% | -$9.9M |
|
Similar funds
John Overdeck's Q1 2015 Portfolio in Review
As of Q1 2015, John Overdeck held 3,174 positions worth $21.5B, up 19% from $18.1B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
John Overdeck deployed $3.03B of net new capital in Q1 2015, opening 981 new positions and adding to 805 existing holdings. Its largest new stake was Intel: 5,084,443 shares worth $159M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 10% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $94.4M trimmed.
- John Overdeck's largest Q1 2015 buy was Intel: 5,084,443 shares worth $159M.
- John Overdeck added most to Johnson & Johnson in Q1 2015, an estimated $161M increase.
- John Overdeck's biggest Q1 2015 reduction was AbbVie, cutting an estimated $94.4M.
- John Overdeck fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $172M.
- John Overdeck's ten largest holdings make up 7.3% of its $21.5B portfolio in Q1 2015.
- John Overdeck opened 981 new positions and closed 576 in Q1 2015.
- John Overdeck's portfolio value rose 19% quarter-over-quarter to $21.5B.
Based on Two Sigma Investments's 13F filing for Q1 2015, filed 15 May 2015.